Navigation Links
Capital Blue Cross Issues Statement on Withdrawal of Merger
Date:1/21/2009

HARRISBURG, Pa., Jan. 21 /PRNewswire/ -- The following statement can be attributed to Michael J. Merenda, Executive Vice President, Capital BlueCross:

"Capital BlueCross has consistently said two things: We are not inherently opposed to this or any other merger. But we have urged public policy makers to think long and hard before approving this proposed merger without conditions, because without conditions the merger would create a single entity controlling 70 percent of Pennsylvania's commercial health insurance market.

"Under the leadership of Pennsylvania Insurance Commissioner Joel Ario, the Commonwealth has done an exemplary job of providing that thoughtful analysis. Commissioner Ario's thorough process sets the standard for review of such complex public-policy proposals.

"The two moving parties announced today that they have decided for their own reasons not to proceed with the merger.

"For us, the withdrawal of their application changes nothing. Our corporate focus will be the same tomorrow as it is today and was yesterday: To do everything we can to help our customers to control health care costs in this most challenging economy. As long as we do that, we will serve our members well, regardless of what other players might do.

"But we do hope that state policy makers will regard this decision as the conclusion of a chapter, not a story. Commissioner Ario's hearings shined a stark light on numerous structural challenges in the Pennsylvania health insurance marketplace, and it is important those challenges continue to be considered, debated and addressed. State Sen. Don White, whose leadership on this issue also has been exemplary, already has indicated he will do just that, and we applaud his commitment and look forward to working with him.

"In the meantime, we look forward to hearing the further comments Commissioner Ario has said he intends to share tomorrow."

Capital BlueCross is an independent licensee of the Blue Cross and Blue Shield Association


'/>"/>
SOURCE Capital BlueCross
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Amilpar - Notice to Shareholders - Distribution of Interest on Capital Stock
2. Hospitals and Health Systems to Cut Back on Both Capital Spending and Unprofitable Services in 2009
3. Onvia Fills Critical Information Gap with Launch of its Economic Stimulus Toolkit, Enabling Businesses to Understand, Prepare for and Capitalize on Pending Stimulus-Driven Opportunities
4. Hard To Treat Diseases (HTDS) Recapitalization
5. Prism Pharmaceuticals to Receive $10 Million Milestone Payment from Paul Capital Healthcare
6. MALO CLINIC Avoids Capital Expense and Gains Scalability with Hosted Unified Communications
7. Daniel J. Nevrivy, Ph.D., Biotech and Pharmaceutical Patent Attorney, Launches New Law Firm Aimed at Helping Clients Preserve Their Capital
8. Memory Pharmaceuticals Regains Compliance with NASDAQ Market Capitalization Requirement
9. Michigan Pre-Seed Capital Fund Invests in Three More Michigan Start-Ups
10. Global Med Technologies(R), Inc. Clarifies Proposal Received from Victory Park Capital Advisors, LLC
11. Global Med Technologies(R) Inc. Receives Unsolicited Proposal From Victory Park Capital Advisors, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... a breakthrough topical cream that’s the first in a new class of photodynamic ... the overall appearance of skin, visibly reduce outward signs of aging, and minimize ...
(Date:4/25/2017)... ... April 25, 2017 , ... As President Trump challenges ... for how his administration could impact the employee benefits industry. James Slotnick, AVP, ... most likely to make it through Congress. His discussion will focus on the ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... rely on contracted partners to help with process innovation in drug formulation and ... formulation experience along with state-of-the-art analytical equipment in support of their development and ...
(Date:4/25/2017)... ... April 25, 2017 , ... Somnoware, a ... its patient care management module. Using this new feature, sleep physicians can now ... initiated on continuous positive airway pressure (CPAP), oral, or other forms of sleep ...
(Date:4/24/2017)... ... April 24, 2017 , ... Emmanuel College is introducing ... advance their careers. Beginning in the fall of 2017, Emmanuel’s program will allow registered ... few as 16 months and for as little as $14,528. These changes will enable ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... India , April 19, 2017 ... and Application, Forecast to 2022 report has covered and analysed ... statistics and information on market size, shares and growth factors. ... major drivers, challenges and opportunities in the global market. ... Browse 152 Tables and Figures, ...
(Date:4/19/2017)... Companion animal vaccines ... pets such as canine, avian and feline. ... such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated ... Recombinant Vaccines. Attenuated live vaccines are derived from ... have been weakend under laboratory conditions. Conjugate vaccines ...
(Date:4/19/2017)... , April 19, 2017  Novartis today ... the National Heart, Lung, and Blood Institute (NHLBI) ... that 58% of patients with treatment-naïve severe aplastic ... when treated with eltrombopag at the initiation of ... The study evaluated three sequential treatment groups, or ...
Breaking Medicine Technology: